Fund holders13F
Funds That Own RHYTHM PHARMACEUTICALS, INC. (RYTM)
2 of the 26 major funds we track reported RYTM in their latest 13F, worth $7.60M combined at quarter end.
| Fund | Quarter | Shares | Value | Change |
|---|---|---|---|---|
| Renaissance Technologies | Q2 2026 | 68,281 | $7.58M | ▼ −73.5% |
| Duquesne Family Office | Q2 2026 | 203,618 | $23K | ▲ New |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
A 13F lists long positions in U.S.-listed stocks and some options at quarter end. It does not show short positions, cash, most foreign holdings, or trades made since. What a 13F can't tell you →